glaucoma is the leading cause of blindness worldwide. It is classically associated with structural and functional changes in the optic nerve head and retinal nerve fiber layer, but the damage is not limited to the eye. The involvement of the central visual pathways and disruption of brain network organization have been reported using advanced neuroimaging techniques. the brain structural changes at the level of the areas implied in processing visual information could justify the discrepancy between signs and symptoms and underlie the analogy of this disease with neurodegenerative dementias, such as alzheimer’s disease, and with the complex group of pathologies commonly referred to as “disconnection syndromes.” this review aims to summarize the current state of the art on the use of advanced neuroimaging techniques in glaucoma and alzheimer’s disease, highlighting the emerging biomarkers shared by both diseases.

Martucci, A., Di Giuliano, F., Minosse, S., Pocobelli, G., Nucci, C., Garaci, F. (2023). MRI and Clinical Biomarkers Overlap between Glaucoma and Alzheimer’s Disease [Banca dati] [10.3390/ijms241914932].

MRI and Clinical Biomarkers Overlap between Glaucoma and Alzheimer’s Disease

Martucci A.;Di Giuliano F.;Minosse S.;Pocobelli G.;Nucci C.;Garaci F.
2023-01-01

Abstract

glaucoma is the leading cause of blindness worldwide. It is classically associated with structural and functional changes in the optic nerve head and retinal nerve fiber layer, but the damage is not limited to the eye. The involvement of the central visual pathways and disruption of brain network organization have been reported using advanced neuroimaging techniques. the brain structural changes at the level of the areas implied in processing visual information could justify the discrepancy between signs and symptoms and underlie the analogy of this disease with neurodegenerative dementias, such as alzheimer’s disease, and with the complex group of pathologies commonly referred to as “disconnection syndromes.” this review aims to summarize the current state of the art on the use of advanced neuroimaging techniques in glaucoma and alzheimer’s disease, highlighting the emerging biomarkers shared by both diseases.
Banca dati
2023
Rilevanza internazionale
Settore MED/30
English
Alzheimer’s disease
clinical biomarkers
diffusion magnetic resonance
functional magnetic resonance
glaucoma
magnetic resonance imaging
neuroimaging
Martucci, A., Di Giuliano, F., Minosse, S., Pocobelli, G., Nucci, C., Garaci, F. (2023). MRI and Clinical Biomarkers Overlap between Glaucoma and Alzheimer’s Disease [Banca dati] [10.3390/ijms241914932].
Martucci, A; Di Giuliano, F; Minosse, S; Pocobelli, G; Nucci, C; Garaci, F
Altro
File in questo prodotto:
File Dimensione Formato  
ijms-24-14932-v2_MRI.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 302.42 kB
Formato Adobe PDF
302.42 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/357263
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact